Mk-0354
| Title | Journal |
|---|---|
| Identification of potent Yes1 kinase inhibitors using a library screening approach. | Bioorganic & medicinal chemistry letters 20130801 |
| (1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic acid (MK-1903): a potent GPR109a agonist that lowers free fatty acids in humans. | Journal of medicinal chemistry 20120426 |
| GPR109a agonists. Part 2: pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109a. | Bioorganic & medicinal chemistry letters 20100801 |
| Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a). | Bioorganic & medicinal chemistry letters 20100501 |
| beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice. | The Journal of clinical investigation 20090501 |
| GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole-tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a. | Bioorganic & medicinal chemistry letters 20090415 |
| 3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice. | Journal of medicinal chemistry 20080828 |